Lowenthal Richard E 的 Form 4 申報
ARS Pharmaceuticals, Inc.（SPRY），2024/5/16 申報
- 申報編號
- 0001415889-24-013387
- 申報時間
- 2024/5/16
- 交易日
- 2024/5/14-5/16
- 申報延遲
- 2 天
- 10b5-1 計畫
- 有勾選
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $90.6 萬。交易後 2 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Lowenthal Richard ECIK 0001378550 | 董事、高階主管（總裁、執行長）、持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/5/14 | Common Stock | S賣出處分 | −2,873 | $9.01F2 | −$25,885.73 | 1,644,574 | 間接 | |
| 2024/5/14 | Common Stock | S賣出處分 | −2,884 | $9.01F4 | −$25,984.84 | 1,795,615 | 間接 | |
| 2024/5/15 | Common Stock | S賣出處分 | −2,381 | $9.05F6 | −$21,548.05 | 1,642,193 | 間接 | |
| 2024/5/15 | Common Stock | S賣出處分 | −2,766 | $9.04F7 | −$25,004.64 | 1,792,849 | 間接 | |
| 2024/5/16 | Common Stock | S賣出處分 | −44,746 | $9.06F8 | −$405,398.76 | 1,597,447 | 間接 | |
| 2024/5/16 | Common Stock | S賣出處分 | −44,350 | $9.06F9 | −$401,811 | 1,748,499 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F2
The weighted average sale price for the transaction reported was $9.0084, and the range of prices were between $9.00 and $9.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F4
The weighted average sale price for the transaction reported was $9.0058, and the range of prices were between $9.00 and $9.06. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F6
The weighted average sale price for the transaction reported was $9.0547, and the range of prices were between $9.00 and $9.16. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F7
The weighted average sale price for the transaction reported was $9.0403, and the range of prices were between $9.00 and $9.12. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F8
The weighted average sale price for the transaction reported was $9.0581, and the range of prices were between $9.00 and $9.13. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。
- F9
The weighted average sale price for the transaction reported was $9.0577, and the range of prices were between $9.00 and $9.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
表 I 有 1 筆交易的價格引用這則附註。